DBV-Technologies – working towards a safer world for allergy sufferers.


The DBV Technologies internet site is a showcase for a medical solution that has the potential to radically improve the lives of millions of people all over the world.

At http://www.dbv-technologies.com/en/viaskin-products/viaskin-plateform you can start to get a feel of why DBV Technologies’ Viaskin platform is causing so much excitement. This adhesive patch is being developed in several variants, including peanut, cows’ milk protein and egg, with other versions at the planning stage, such as shellfish. The patch adopts the epicutaneous approach to immunotherapy. This means no to injections and oral treatments and yes to a pain-free treatment that is especially suitable for administration to children.

The use of the Viaskin patch is central to DBV Technologies’ epicutaneous approach

Source: http://www.dbv-technologies.com

As you can see in the picture below, the patch is small enough to be worn discreetly on the patient’s arm, and may be taken off and put back on at will. It works by releasing very small amounts of the relevant antigen into the body through the skin. This helps the patient’s immune system to become tolerized to this substance without the risk of anaphylaxis. In time, the individual allergy sufferer should be able to ingest foodstuffs that would previously have triggered an allergic reaction, without suffering any ill-effects.


About Author

Comments are closed.